Skip to main content

Advertisement

Log in

Alternatives to the QALY measure for economic evaluations

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Economic analyses (i.e., analyses that are concerned primarily with questions of resource allocation) are becoming more common in health care in general and care of cancer patients in particular. The most commonly used measure for the valuation of outcome in such analyses is the QALY (quality-adjusted life-years), which combines qualitative (i.e., quality of life) and quantitative (i.e., survival) aspects of the outcome into one dimension. Using economics (i.e., the discipline) as the mode of thinking to help solve problems of resource allocation in health, this paper describes a framework to evaluate the appropriateness of use of a measure of outcome in the context of an economic evaluation. This framework will be used to critically appraise the use of the QALY measure and of two alternative measures, HYE (healthy years equivalent) and WTP (willingness to pay), in economic evaluations of health care interventions. The paper also describes a practical tool that can be used to measure individuals' WTP in the context of public decision making. This tool involves modifying the decision board, a tool developed (originally in the cancer area) to help clinicians present information to patients. The intent is to show that the use of a theoretically superior measure of outcome need not always be empirically restrictive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Arrow KJ (1971) Uncertainty and the welfare economics of medical care. In: Arrow KH (ed) Essays in the theory of risk-bearing. Markham, Chicago, pp 177–219

    Google Scholar 

  2. Bell DE, Farquhar PH (1986) Perspectives on utility theory. Operations Res 34: 179–183

    Google Scholar 

  3. Ben Zion U, Gafni A (1983) Evaluation of public investment in health care: Is the risk irrelevant? J Health Eton 2: 161–165

    Google Scholar 

  4. Bleicbrodt H (1995) QALYs and HYEs: under what conditions are they equivalent? J Health Econ 14: 17–37

    Google Scholar 

  5. Broome J (1993) QALYs. J Publ Econ 50: 149–167

    Google Scholar 

  6. Culyer AJ (1981) Health, economics and health economics. In: VanderGang J, Perlman M (eds) Health, economics and health economics. North-Holland, Amsterdam, pp 3–11

    Google Scholar 

  7. Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B (1996) Patient's preferences for therapy in advanced epithelial ovarian cancer: development, testing and application of a bedside decision instrument. Gynecol Oncol J 62: 329–335

    Google Scholar 

  8. Evans RG (1984) Strained mercy: the economics of Canadian health care. Butterworths, Toronto

    Google Scholar 

  9. Fishburn PC (1988) Expected utility: an anniversary and a new era. J Risk Uncertainty 1: 267–288

    Google Scholar 

  10. Gafni A (1991) Using willingness-topay as a measure of benefits: what is the relevant question to ask in the context of public decision making about health care programs. Med Care 29: 1246–1252

    Google Scholar 

  11. Gafni A (1996) Proper preference based outcome measures in economic evaluations of pharmaceutical interventions. Med Care (in press)

  12. Gafni A, Birch S (1991) Equity considerations in utility-based measures of health outcome in economic appraisals: an adjustment algorithm. J Health Econ 10: 329–342

    Google Scholar 

  13. Gafni A, Birch S (1995) Preferences for outcomes in economic evaluations: an economic approach to ad dressing economic problems. Soc Sci Med 40: 767–776

    Google Scholar 

  14. Gafni A, Birch S, Mehrez A (1993) Economics, health and health economics: HYEs versus QALYs. J Health Econ 12: 325–339

    Google Scholar 

  15. Johannesson M (1995) The ranking properties of healthy years equivalents and quality adjusted life years under certainty and uncertainty. Int J Technol Assess Health Care 11: 40–48

    Google Scholar 

  16. Kaplan RM, Feeny D, Revicki DA (1993) Methods for assessing relative importance in preference based outcome measure. Qual Life Res 2: 467–475

    Google Scholar 

  17. Labelle RJ, Hurley JE (1992) Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities. J Health Eton 11: 259–277

    Google Scholar 

  18. Levine MN, Gafni A, Markham B, MacFarlane B (1992) A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117: 53–58

    Google Scholar 

  19. Machina MJ (1987) Choice under uncertainty: problems solved and unsolved. Econ Perspect 1: 121–154

    Google Scholar 

  20. Mehrez A, Gafni A (1989) Quality adjusted life years, utility theory, and healthy years equivalents. Med Decis Making 9: 142–149

    Google Scholar 

  21. Mehrez A, Gafni A (1991) The healthy years equivalent: how to measure them using the standard gamble approach. Med Decis Malting 11: 140–146

    Google Scholar 

  22. Mishan EJ (1971) Elements of costbenefit analysis. Allen and Unwin, London

    Google Scholar 

  23. Mooney G (1986) Economics, medicine and health care. Wheatsheaf, Brighton

    Google Scholar 

  24. O'Brien B, Gafni A (1995) When do ‘dollars’ make sense? Towards a conceptual framework for contingent valuation studies in health care. Med Decis Making 16: 288–302

    Google Scholar 

  25. Phelps CE (1992) Health economics. Harper Collins, New York

    Google Scholar 

  26. Pliskin JS, Shephard DS, Weinstein MC (1980) Utility functions for life years and health status. Operations Res 28: 206–224

    Google Scholar 

  27. Richardson J (1994) Cost-utility analysis: what should be measured? Soc Sci Med 39: 7–21

    Google Scholar 

  28. Sebban C, Browman G, Gafni A, Norman G, Levine MN, Assouline D, Fiere D (1995) Design and validation of a bedside decision instrument to elicit a patient's preferences concerning allogenic bone marrow transplantation in chronic myeloid leukemia. Am J Hematol 48: 221–227

    Google Scholar 

  29. Torrance GW, Feeny D (1989) Utilities and quality-adjusted life-years. Int J Technol Assess Health Care 3: 559–575

    Google Scholar 

  30. Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide EA, Patel M, Streiner DL (1995) Breast irradiation post lumpectomy: development and evaluation of a decision instrument. J Clin Oncol 13: 847–853

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gafni, A. Alternatives to the QALY measure for economic evaluations. Support Care Cancer 5, 105–111 (1997). https://doi.org/10.1007/BF01262566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01262566

Key words

Navigation